<div id="readability-page-1"><p><span>Ares Capital (NASDAQ:ARCC - Get Free Report)</span> had its price objective lowered by stock analysts at UBS Group  from $22.00 to $21.00 in a report issued on Thursday,Benzinga reports. The brokerage currently has a &#34;neutral&#34; rating on the investment management company's stock. UBS Group's price objective would indicate a potential upside of 2.46% from the stock's current price.</p><ul><li>Maximize Your Returns: 3 Dividend Stocks With Yields Over 5%</li></ul><p>A number of other equities analysts also recently commented on the stock. StockNews.com downgraded shares of Ares Capital from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a report on Friday, February 7th. JPMorgan Chase &amp; Co. raised their price target on Ares Capital from $23.00 to $24.50 and gave the stock an &#34;overweight&#34; rating in a report on Monday, February 3rd. Raymond James cut Ares Capital from an &#34;outperform&#34; rating to a &#34;market perform&#34; rating in a research note on Thursday, February 6th. Wells Fargo &amp; Company cut their price objective on shares of Ares Capital from $24.00 to $23.00 and set an &#34;overweight&#34; rating on the stock in a research report on Thursday, February 6th. Finally, Keefe, Bruyette &amp; Woods reduced their price objective on Ares Capital from $23.00 to $22.00 and set an &#34;outperform&#34; rating for the company in a research report on Tuesday, April 8th. One investment analyst  has rated the stock with a sell rating, three have assigned  a hold rating, seven have assigned  a buy rating and one  has issued  a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $22.61.</p><p><b>Check Out Our Latest Stock Analysis on ARCC</b></p><h2>Ares Capital Stock Up 2.0 %</h2><ul><li>3 Dividend-Yielding Stocks Too Cheap to Pass Up</li></ul><p>Shares of ARCC traded up $0.41 during trading on Thursday, reaching $20.50. The company's stock had a trading volume of 2,723,395 shares, compared to its average volume of 4,028,801. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 1.03. The company has a fifty day moving average of $21.95 and a two-hundred day moving average of $21.95. The company has a market cap of $14.03 billion, a price-to-earnings ratio of 8.37 and a beta of 0.77. Ares Capital has a twelve month low of $18.26 and a twelve month high of $23.84. </p><p>Ares Capital (NASDAQ:ARCC - Get Free Report) last released its earnings results on Wednesday, February 5th. The investment management company reported $0.55 earnings per share for the quarter, missing the consensus estimate of $0.58 by ($0.03). Ares Capital had a return on equity of 11.54% and a net margin of 50.90%.  On average, sell-side analysts predict that  Ares Capital will post 2.19 EPS for the current fiscal year. </p><h2>Institutional Trading of Ares Capital</h2><p>Several institutional investors and hedge funds have recently bought and sold shares of the stock. Montag &amp; Caldwell LLC purchased a new stake in shares of  Ares Capital in the 4th quarter valued at approximately $33,000.  VSM Wealth Advisory LLC acquired a new stake in shares of  Ares Capital in the fourth quarter worth $35,000.  Promus Capital LLC purchased a new position in shares of  Ares Capital during the fourth quarter valued at $48,000.  SRS Capital Advisors Inc. acquired a new position in  Ares Capital during the fourth quarter valued at $60,000.  Finally, Montag A &amp; Associates Inc. boosted its position in  Ares Capital by 92.6% during the 4th quarter. Montag A &amp; Associates Inc. now owns 2,889 shares of the investment management company's stock worth $63,000 after acquiring an additional 1,389 shares during the period. Institutional investors and hedge funds own  27.38% of the company's stock. </p><h2>Ares Capital Company Profile</h2> (Get Free Report)<p>Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Ares Capital</li><li>With Risk Tolerance, One Size Does Not Fit All</li><li>Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally</li><li>How to Most Effectively Use the MarketBeat Earnings Screener</li><li>Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar</li><li>How to Invest in Biotech Stocks</li><li>Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVJDQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVJDQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Ares Capital Right Now?</h2><p>Before you consider Ares Capital, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ares Capital wasn't on the list.</p><p>While Ares Capital currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ARCC

<p>UBS Group has lowered its price target for Ares Capital (NASDAQ:ARCC) from $22.00 to $21.00, maintaining a "neutral" rating. This adjustment suggests a potential upside of 2.46% from the current stock price. Other analysts have varied opinions, with some downgrading the stock while others have raised their targets. Ares Capital's stock recently traded at $20.50, with a market cap of $14.03 billion and a price-to-earnings ratio of 8.37. The company reported earnings of $0.55 per share, missing estimates by $0.03.</p>

UBS Group Issues Pessimistic Forecast for Ares Capital (NASDAQ:ARCC) Stock Price